• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Med Clin (Barc) Effect of Vaccination on the Prevention of Influenza-Related Severe Illness in Adults Attended in a Third Level Hospital During the 2

tetano

Editor, Senior Moderator
Med Clin (Barc)


. 2020 May 15;S0025-7753(20)30183-4.
doi: 10.1016/j.medcli.2020.01.030. Online ahead of print.
Effect of Vaccination on the Prevention of Influenza-Related Severe Illness in Adults Attended in a Third Level Hospital During the 2017-2018 Epidemic Season


[Article in English, Spanish]

Guillermo Mena[SUP] 1 [/SUP], Irma Casas[SUP] 2 [/SUP], Cristina Prat[SUP] 3 [/SUP], Cristina Casa?[SUP] 4 [/SUP], Mar?a Esteve[SUP] 1 [/SUP], Agust?n Urrutia[SUP] 5 [/SUP], Josep-Maria M?dol[SUP] 6 [/SUP]



Affiliations

Abstract

Objectives: The objective of this research was to evaluate the effect of influenza vaccination on the prevention of influenza-related severe cases in adults treated in a third-level hospital during the 2017-2018 epidemic season.
Methodology: A descriptive analysis was performed on the entire population of subjects with a laboratory-confirmed influenza test during the 2017-2018 season. A severe case was defined as a patient treated in one of the Intensive Care Units (ICUs) and/or death. The effect of the vaccine on the adult population was determined by multivariate logistic regression analysis.
Results: Between epidemiological weeks 44/2017 and 19/2018, the hospital's laboratory detected 706 positive samples for influenza virus. Of the 551 confirmed patients aged 18 years or older, forty-three were admitted to one of the ICUs, and 26 died during admission. The explanatory multivariate model has shown that flu vaccination prior to or during the epidemic season was a protective factor for the development of severity [OR:0.27 (0.11-0.65, p=0.004)], adjusted by age [OR: 1.03 (1.01-1.06), p=.04], sex, type of virus (H1N1-pdm09, H3N2 or B virus), Chronic Complex Patient index or Advanced Chronic Disease index.
Conclussions: Influenza vaccination is a protective factor against the development of severity associated with influenza infection in a season when vaccination did not contain the virus with higher epidemic circulation among the population. Flu vaccination should be recommended annually following the guidelines established by the health authorities.

Keywords: Efectividad; Effectiveness; Epidemiologia; Epidemiology; Flu; Gravedad; Gripe; Hospital; Severity; Vaccine; Vacuna.
 
Back
Top Bottom